动脉粥样硬化性心血管疾病仍然是全球范围内人类死亡的主要原因之一.血脂异常是动脉粥样硬化最重要的危险因素.他汀类药物是降低血......

Gernfibrozil is a widely used lipid modifying drug with well-established hypolipidemic and anti-atherosclerotic benefits......

目的 研究吉非罗齐、非诺贝特和苯扎贝特3种贝特类药物对心、脑血管事件的作用.方法 系统性检索Cochrane图书馆临床对照试验数据库......

目的：探讨调血脂药致横纹肌溶解症的一般规律及特点。方法：以＂横纹肌溶解症＂为关键词,对近10年＂中国期刊全文数据库＂收录的文献进行检索......

The use of fibrates in the treatment of dyslipidaemia has changed significantly over recent years.Their role appeared cl......

Diabetic retinopathy affects a substantial proportion of patients with diabetes mellitus(DM) and is the leading cause of......

Nonalcoholic fatty liver disease(NAFLD) is the most common chronic liver disease in developed countries and is associate......

Objective: This study compared the effects of combination statin and fibrate therapy with either statin or fibrate monot......

Objective: This study compared the effects of combination statin and fibrate therapy with either statin or fibrate monot......

The cardioprotective effects of lipid-lowering drugs have been primarily attributed to their effects on blood lipid meta......